LIMES Schlosskliniken AG

XTRA:LIK Voorraadrapport

Marktkapitalisatie: €108.5m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

LIMES Schlosskliniken Toekomstige groei

Future criteriumcontroles 1/6

LIMES Schlosskliniken is forecast to grow revenue at 19.8% per annum.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Healthcare winstgroei20.6%
Inkomstengroei19.8%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt03 Apr 2024

Recente toekomstige groei-updates

Recent updates

LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit

May 21
LIMES Schlosskliniken's (ETR:LIK) Problems Go Beyond Weak Profit

Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)

Apr 12
Why We Like The Returns At LIMES Schlosskliniken (ETR:LIK)

Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)

Sep 07
Returns on Capital Paint A Bright Future For LIMES Schlosskliniken (ETR:LIK)

Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive

Dec 21
Under The Bonnet, LIMES Schlosskliniken's (ETR:LIK) Returns Look Impressive

LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon

Sep 24
LIMES Schlosskliniken AG's (ETR:LIK) Shares May Have Run Too Fast Too Soon

LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations

May 23
LIMES Schlosskliniken's (ETR:LIK) Promising Earnings May Rest On Soft Foundations

LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price

Mar 24
LIMES Schlosskliniken (ETR:LIK) Is Doing The Right Things To Multiply Its Share Price

Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly

Nov 16
Here's Why LIMES Schlosskliniken (ETR:LIK) Can Manage Its Debt Responsibly

Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?

May 17
Would LIMES Schlosskliniken (ETR:LIK) Be Better Off With Less Debt?

Winst- en omzetgroeiprognoses

XTRA:LIK - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202666N/AN/AN/A1
12/31/202556N/AN/AN/A1
12/31/202443N/AN/AN/A1
6/30/202442405N/A
3/31/2024394-26N/A
12/31/2023373-46N/A
9/30/2023333-26N/A
6/30/202330306N/A
3/31/202329437N/A
12/31/202229478N/A
9/30/202229448N/A
6/30/202229429N/A
3/31/202226407N/A
12/31/2021234-25N/A
9/30/2021193N/AN/AN/A
6/30/2021152N/AN/AN/A
3/31/2021130N/AN/AN/A
12/31/202011-1-11N/A
9/30/202010-1N/AN/AN/A
6/30/20209-1N/AN/AN/A
3/31/20209-1N/AN/AN/A
12/31/20198-1N/AN/AN/A
9/30/20198-1N/AN/AN/A
6/30/20198-1N/AN/AN/A
3/31/20198-1N/AN/AN/A
12/31/20188-1N/AN/AN/A
12/31/20177-1N/AN/AN/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if LIK's forecast earnings growth is above the savings rate (0.8%).

Winst versus markt: Insufficient data to determine if LIK's earnings are forecast to grow faster than the German market

Hoge groeiwinsten: Insufficient data to determine if LIK's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: LIK's revenue (19.8% per year) is forecast to grow faster than the German market (5.4% per year).

Hoge groei-inkomsten: LIK's revenue (19.8% per year) is forecast to grow slower than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if LIK's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven